Your shopping cart is currently empty

T14-A24 is an orally active, reversible, competitive, and selective AChE inhibitor with a Ki of 22 nM and an IC50 of 6 nM. It displays excellent blood-brain barrier penetration, significant neuroprotective effects, and favorable toxicological characteristics.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | T14-A24 is an orally active, reversible, competitive, and selective AChE inhibitor with a Ki of 22 nM and an IC50 of 6 nM. It displays excellent blood-brain barrier penetration, significant neuroprotective effects, and favorable toxicological characteristics. |
| Targets&IC50 | AChE:22 nM (Ki) |
| In vivo | T14-A24 (10 mg/kg, orally) has been shown to enhance cognitive performance impaired by Aβ1-42 and significantly mitigate the toxic effects of Aβ1-42 in mice. |
| Formula | C24H24N6O3S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.